Search Results
You are looking at 1 - 3 of 3 items for
- Author: Samuel M O'Toole x
- Refine by access: All content x
Search for other papers by Samuel M O'Toole in
Google Scholar
PubMed
Search for other papers by Judit Dénes in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
The combination of pituitary adenomas (PA) and phaeochromocytomas (phaeo) or paragangliomas (PGL) is a rare event. Although these endocrine tumours may occur together by coincidence, there is mounting evidence that, in at least some cases, classical phaeo/PGL-predisposing genes may also play a role in pituitary tumorigenesis. A new condition that we termed ‘3Pas’ for the association of PA with phaeo and/or PGL was recently described in patients with succinate dehydrogenase mutations and PAs. It should also be noted that the classical tumour suppressor gene, MEN1 that is the archetype of the PA-predisposing genes, is also rarely associated with phaeos in both mice and humans with MEN1 defects. In this report, we review the data leading to the discovery of 3PAs, other associations linking PAs with phaeos and/or PGLs, and the corresponding clinical and molecular genetics.
Search for other papers by Samuel M O’Toole in
Google Scholar
PubMed
Search for other papers by Anju Sahdev in
Google Scholar
PubMed
Search for other papers by Satya Bhattacharya in
Google Scholar
PubMed
Search for other papers by Roger Feakins in
Google Scholar
PubMed
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Search for other papers by William M Drake in
Google Scholar
PubMed
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Samuel M O’Toole in
Google Scholar
PubMed
Search for other papers by David S Watson in
Google Scholar
PubMed
Search for other papers by Tatiana V Novoselova in
Google Scholar
PubMed
Search for other papers by Lisa E L Romano in
Google Scholar
PubMed
Search for other papers by Peter J King in
Google Scholar
PubMed
Search for other papers by Teisha Y Bradshaw in
Google Scholar
PubMed
Search for other papers by Clare L Thompson in
Google Scholar
PubMed
Search for other papers by Martin M Knight in
Google Scholar
PubMed
Search for other papers by Tyson V Sharp in
Google Scholar
PubMed
Search for other papers by Michael R Barnes in
Google Scholar
PubMed
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Department of Diabetes and Endocrinology, University College London Hospital, London, UK
Search for other papers by Umasuthan Srirangalingam in
Google Scholar
PubMed
Search for other papers by William M Drake in
Google Scholar
PubMed
Search for other papers by J Paul Chapple in
Google Scholar
PubMed
Primary cilia are sensory organelles involved in regulation of cellular signaling. Cilia loss is frequently observed in tumors; yet, the responsible mechanisms and consequences for tumorigenesis remain unclear. We demonstrate that cilia structure and function is disrupted in human pheochromocytomas – endocrine tumors of the adrenal medulla. This is concomitant with transcriptional changes within cilia-mediated signaling pathways that are associated with tumorigenesis generally and pheochromocytomas specifically. Importantly, cilia loss was most dramatic in patients with germline mutations in the pseudohypoxia-linked genes SDHx and VHL. Using a pheochromocytoma cell line derived from rat, we show that hypoxia and oncometabolite-induced pseudohypoxia are key drivers of cilia loss and identify that this is dependent on activation of an Aurora-A/HDAC6 cilia resorption pathway. We also show cilia loss drives dramatic transcriptional changes associated with proliferation and tumorigenesis. Our data provide evidence for primary cilia dysfunction contributing to pathogenesis of pheochromocytoma by a hypoxic/pseudohypoxic mechanism and implicates oncometabolites as ciliary regulators. This is important as pheochromocytomas can cause mortality by mechanisms including catecholamine production and malignant transformation, while hypoxia is a general feature of solid tumors. Moreover, pseudohypoxia-induced cilia resorption can be pharmacologically inhibited, suggesting potential for therapeutic intervention.
